Lumea
michael frampton is a Director of Product at Lumea since September 2017, where he also holds the title of Interaction Designer. Previously, he worked as a Graduate Capstone Project - Experience Designer at Seattle Children's from March 2017 to August 2017. With a background in Computer Science & Bioinformatics, michael also has experience as a Software Developer at Leavitt Medical from December 2013 to August 2016. Additionally, he served as a Software Developer Intern at Tute Genomics in June 2015. Michael furthered his education at the University of Washington, earning a Master of Human-Computer Interaction + Design degree in 2017 after completing his Bachelor's degree at Brigham Young University in 2016.
This person is not in any teams
Lumea
Lumea is reshaping the pathology landscape with innovative technology solutions that elevate and enhance the entire pathology ecosystem. Since its founding in 2013, Lumea has pioneered one of the first software platforms of its kind, offering a comprehensive suite of products, including proprietary specimen-handling consumables, a digitally-enabled Laboratory Information System (LIS), and a premier IMS/Viewer. Lumea’s unique approach to digital pathology not only increases cancer detection rates but also delivers a substantial return on investment in a cost-sensitive environment and ultimately sets a higher standard of patient care in cancer diagnostics. With over 1.5 million digital diagnoses, Lumea ranks among the top 5 digital pathology platforms for clinical use in the United States. For further insights into the transformative benefits of Lumea technology, visit lumeadigital.com.